Literature DB >> 19231290

Phenotypic differences between BCG vaccines at the proteome level.

Mauricio Rodríguez-Alvarez1, Guillermo Mendoza-Hernández, Sergio Encarnación, Juan José Calva, Yolanda López-Vidal.   

Abstract

To contribute to Mycobacterium bovis BCG characterization, two substrains were analyzed using two-dimensional gel electrophoresis (2D-PAGE) and mass spectrometry (MS), based on their protective efficacy in a pulmonary-tuberculosis mouse model. Cell-fraction proteins of BCG Denmark and Phipps substrains were separated into approximately 500 spots in 2D-PAGE. The proteomes were similar in protein number, and isoelectric point (pI) and molecular mass (MM) distribution. Statistical analysis, resulted in 72 spots with no change, and 168 and 90 unique for BCG Phipps or Denmark, respectively. Two hundred and fourteen spots showed changes in intensity of >1-fold, 138 of Denmark, and 76 of Phipps. Seventeen spots were selected for MS-based identification (13 from Phipps and 4 from Denmark), including unique, as well as proteins with changes in intensity. The proteins identified participate in virulence, detoxification, adaptation, lipid metabolism, information pathways, cell wall and cell processes, intermediary metabolism and respiration, or still hypotheticals. Our findings contribute to phenotype characterization of BCG substrains and provide new elements to consider for the design of diagnostic tools, drug targets and a new vaccine against tuberculosis based upon protein expression through quantitative statistical analysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231290     DOI: 10.1016/j.tube.2008.12.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  6 in total

1.  Potential cross-reactivity of monoclonal antibodies against clinically relevant mycobacteria.

Authors:  K Flores-Moreno; J S Celis-Meneses; D M Meneses-Ruiz; A I Castillo-Rodal; P Orduña; B A Montiel; Y López-Vidal
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

Review 2.  Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.

Authors:  Yuan-qiang Zheng; Youssef W Naguib; Yixuan Dong; Yan-chun Shi; Shorgan Bou; Zhengrong Cui
Journal:  Expert Rev Vaccines       Date:  2015       Impact factor: 5.217

3.  Genomic and proteomic analyses of Mycobacterium bovis BCG Mexico 1931 reveal a diverse immunogenic repertoire against tuberculosis infection.

Authors:  Patricia Orduña; Miguel A Cevallos; Samuel Ponce de León; Adriana Arvizu; Ismael L Hernández-González; Guillermo Mendoza-Hernández; Yolanda López-Vidal
Journal:  BMC Genomics       Date:  2011-10-08       Impact factor: 3.969

4.  Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur.

Authors:  Marcia Berrêdo-Pinho; Dario E Kalume; Paloma R Correa; Leonardo H F Gomes; Melissa P Pereira; Renata F da Silva; Luiz R R Castello-Branco; Wim M Degrave; Leila Mendonça-Lima
Journal:  BMC Microbiol       Date:  2011-04-20       Impact factor: 3.605

5.  Specific Proteins in Nontuberculous Mycobacteria: New Potential Tools.

Authors:  Patricia Orduña; Antonia I Castillo-Rodal; Martha E Mercado; Samuel Ponce de León; Yolanda López-Vidal
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

6.  Comparative Proteomic Profiling of Mycobacterium tuberculosis and the Thai Vaccine Strain Mycobacterium bovis Bacille Calmette-Guerin Tokyo172: Diverse Biomarker Candidates for Species Differentiation.

Authors:  Songsri Kasempimolporn; Pornpimol Premchaiporn; Wichit Thaveekarn; Supatsorn Boonchang; Visith Sitprija
Journal:  J Glob Infect Dis       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.